The HHS Tuesday proposed further delaying a Trump administration drug rule that requires community health centers to pass on all their insulin and epinephrine discount savings to patients.
Centers that don’t pass on the savings wouldn’t qualify for federal grants. The Department of Health and Human Services under President Joe Biden delayed the effective date of the rule (RIN 0906-AB25) until March 22. It was finalized in late December. The HHS is now proposing to delay the effective date until July 20 to give agency officials more opportunity to review the rule and take additional comments.
The freeze is part ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.